Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2000 Feb;21(2):375-80.

MR spectroscopy in gliomatosis cerebri

Affiliations
Case Reports

MR spectroscopy in gliomatosis cerebri

M Bendszus et al. AJNR Am J Neuroradiol. 2000 Feb.

Abstract

Background and purpose: The diagnosis of gliomatosis cerebri with MR imaging is known to be difficult. We report on the value of MR spectroscopy in the diagnosis, grading, and biopsy planing in eight patients with histopathologically proved gliomatosis cerebri.

Methods: Patients underwent MR imaging and MR spectroscopy (single-voxel point-resolved spectroscopy [PRESS] at 1500/135, and chemical-shift imaging [CSI] PRESS at 1500/135) before open (n = 4) or stereotactic (n = 4) biopsy. In six patients who underwent CSI, biopsy samples were taken from regions of maximally elevated levels of choline/N-acetylaspartate (Cho/NAA).

Results: All patients showed elevated Cho/creatine (Cr) and Cho/NAA levels as well as varying degrees of decreased NAA/Cr ratios, which were most pronounced in the anaplastic lesions. In low-grade lesions, there was a maximum Cho/NAA ratio of 1.3, whereas in anaplastic tumors, the maximum Cho/NAA level was at least 2.5. Spectra in two patients with grade III lesions revealed a lactate peak; lactate and lipid signals were seen in two patients with grade IV lesions. Biopsy specimens from regions with maximally elevated levels of Cho/NAA showed dense infiltration of tumor cells.

Conclusion: MR spectroscopy might be used to classify gliomatosis cerebri as a stable or a progressive disease indicating its potential therapeutic relevance.

PubMed Disclaimer

Figures

<sc>fig</sc> 1.
fig 1.
Case 4: 38-year-old woman with bifrontal hyperintensity and tumor spread via corpus callosum. A, Axial T2-weighted spin-echo localizer image (1900/80). B, Corresponding spectrum (CSI, PRESS, 1500/135, voxel size = 7.5 × 7.5 × 15 mm) shows a moderate increase in Cho/Cr and Cho/NAA and a decrease in NAA/Cr.
<sc>fig</sc> 2.
fig 2.
Case 5: 12-year-old boy with seizure. A, Axial T1-weighted localizer image (fast low-angle shot, 80/10) shows extensive hypointense infiltration of the right hemisphere with little mass effect. B, Corresponding spectrum (CSI, PRESS, 1500/135, voxel size = 7.5 × 7.5 × 15 mm) shows a marked increase in Cho/Cr and Cho/NAA and a pronounced decrease in NAA/Cr. Moreover, there is a lactate doublet at 1.35 ppm.
<sc>fig</sc> 3.
fig 3.
Case 8: 55-year-old man with diffuse involvement of both hemispheres. A, Axial T2-weighted spin-echo localizer image (1900/80). B, Corresponding spectrum. Stereotactic biopsy sample was taken from the denoted voxel, with a maximum Cho/NAA ratio of the lesion of 8.9 as well as a lactate doublet at 1.35 ppm. Histopathologic examination revealed a grade IV tumor. In other areas of the tumor there were lipid signals at 0.8 to 1.3 ppm (CSI, PRESS, 1500/135, voxel size = 7.5 × 7.5 × 15 mm). fig 4. Case 1: 10-year-old boy with seizure. Axial spin-echo T2-weighted image (1900/80) shows extensive hyperintensity of the left occipital, parietal, and temporal lobes, with infiltration of the thalamus and the insula. Both gray and white matter are affected, and there is little mass effect
<sc>fig</sc> 5.
fig 5.
Metabolite ratios for Cho/Cr, NAA/Cr, and Cho/NAA. The difference between the histopathologic tumor grades is most pronounced in the Cho/NAA ratio. In the group of low-grade lesions, the maximum Cho/NAA level is 1.3, whereas in anaplastic tumors, the Cho/NAA ratio is at least 2.5 with a maximum value of 8.9 in a grade IV lesion

References

    1. Kleihues P, Burger PC, Scheithauer PW. The new WHO classification of brain tumors. Brain Pathol 1993;3:255-268 - PubMed
    1. Couch JR, Weiss SA. Gliomatosis cerebri. Neurology 1974;24:504-511 - PubMed
    1. Nevin S. Gliomatosis cerebri. Brain 1938;61:170-191
    1. Carpio-O'Donovan R, Korah I, Salazar A, Melacon D. Gliomatosis cerebri. Radiology 1996;198:831-835 - PubMed
    1. Burger PC, Scheithauer BW. Atlas of Tumor Pathology: Tumors of the Central Nervous System. Washington, DC: Armed Forces Institute of Pathology; 1994: 3rd series, fasc. 10

Publication types

MeSH terms